NYSE : WAT
Waters Corporation — Key statistics
Healthcare · Diagnostics & Research · United States
Last price 469.95 USD (Oct 30, 2026, 9:56 AM EDT) · Market cap 46.17B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 45.46B |
| Enterprise Value | 50.40B |
Dates
| Measure | Value |
|---|
| Earnings Date | Nov 3, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 98.25M |
| Shares Outstanding | 98.25M |
| Shares Change (YoY) | +25.49% |
| Shares Change (QoQ) | +19.56% |
| Owned by Insiders (%) | 0.08% |
| Owned by Institutions (%) | 101.40% |
| Float | 98.06M |
Ratios
| Measure | Value |
|---|
| PE Ratio | 208.92 |
| Forward PE | 29.83 |
| PS Ratio | 9.79 |
| Forward PS | 6.60 |
| PB Ratio | 2.99 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 113.99 |
| P/OCF Ratio | 82.72 |
| PEG Ratio | 2.38 |
Evratios
| Measure | Value |
|---|
| EV / Earnings | 302.46 |
| EV / Sales | 10.85 |
| EV / EBITDA | 34.71 |
| EV / EBIT | 60.08 |
| EV / FCF | 126.37 |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 1.86 |
| Quick Ratio | 1.05 |
| Debt / Equity | 0.36 |
| Debt / EBITDA | 3.67 |
| Debt / FCF | 13.73 |
| Interest Coverage | 5.61 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | 1.92% |
| Return on Assets (ROA) | 3.56% |
| Return on Invested Capital (ROIC) | 3.35% |
| Return on Capital Employed (ROCE) | 3.75% |
| Weighted Average Cost of Capital (WACC) | 9.67% |
| Revenue Per Employee | $587,884 |
| Profits Per Employee | $21,092 |
| Employee Count | 7,900 |
| Asset Turnover | 0.32 |
| Inventory Turnover | 2.11 |
Taxes
| Measure | Value |
|---|
| Income Tax | 39.25M |
| Effective Tax Rate | 19.06% |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 1.15 |
| 52-Week Price Change | +34.72% |
| 50-Day Moving Average | 430.19 |
| 200-Day Moving Average | 369.52 |
| Relative Strength Index (RSI) | 59.88 |
| Average Volume (20 Days) | 941,121 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 3.19M |
| Short Previous Month | 3.30M |
| Short % of Shares Out | 3.25% |
| Short % of Float | 3.25% |
| Short Ratio (days to cover) | 3.72 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 4.64B |
| Gross Profit | 2.62B |
| Operating Income | 838.81M |
| Pretax Income | 205.88M |
| Net Income | 166.63M |
| EBITDA | 1.45B |
| EBIT | 838.81M |
| Earnings Per Share (EPS) | $2.21 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 539.00M |
| Total Debt | 5.48B |
| Net Cash | -4.94B |
| Net Cash Per Share | -$50.26 |
| Equity (Book Value) | 15.20B |
| Book Value Per Share | 154.70 |
| Working Capital | 2.07B |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | 549.56M |
| Capital Expenditures | -150.75M |
| Depreciation & Amortization | 613.24M |
| Net Borrowing | -348.00M |
| Free Cash Flow | 398.81M |
| FCF Per Share | $4.06 |
Margins
| Measure | Value |
|---|
| Gross Margin | 56.34% |
| Operating Margin | 18.06% |
| Pretax Margin | 4.43% |
| Profit Margin | 3.59% |
| EBITDA Margin | 31.27% |
| EBIT Margin | 18.06% |
| FCF Margin | 8.59% |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -25.49% |
| Shareholder Yield | -25.49% |
| Earnings Yield | 0.48% |
| FCF Yield | 0.88% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $465.86 |
| Price Target Difference | 0.68% |
| Analyst Consensus | Buy |
| Analyst Count | 23 |
| Revenue Growth Forecast (3Y) | 33.76% |
| EPS Growth Forecast (3Y) | 12.35% |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | Aug 28, 2000 |
| Split Type | Forward |
| Split Ratio | 2:1 |
Scores
| Measure | Value |
|---|
| Altman Z-Score | 2.56 |
| Piotroski F-Score | 5 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |